GSK Consumer Tries On Wearable Pain Relief With NeuroMetrix Deal

GSK Consumer purchases outside-of-US rights to pain-relief device Quell from NeuroMetrix in a deal that includes co-development of transcutaneous electrical nerve stimulation products.

GlaxoSmithKline PLC is preparing for a big splash in the over-the-counter device space by acquiring ex-US rights to NeuroMetrix Inc.'s Quell wearable pain-relief technology and working with the firm on additional transcutaneous electrical nerve stimulation (TENS) products.

GSK Consumer Healthcare LP, Glaxo's OTC and dietary supplement joint venture with Novartis AG, will pay $5m for Quell...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Digital Technologies

More from Medtech Insight